Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term hepatitis A and B antibody persistence after Twinrix priming
2013-004586-13Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2014
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hepatitis b vaccine recombinant in hepatitis A (HAV) and hepatitis B (HBV), sponsored by GSK. Primary endpoints: Anti-HBs antibody persistence and Antibody titres to vaccine components. Started Apr 2014; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on 2013-004586-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-004586-13.